November's data screams one clear message: size matters dramatically. The under $500M cohort collapsed 51.7% on average, while companies above $5B moved barely at all or even positive. This isn't just about liquidity, it's about the complete absence of institutional defense mechanisms that protect larger companies. Fugazi and BMF's devastation of Davis Commodities shows what's possible when quality research meets minimal market cap. For researchers optimizing for immediate, measurable impact, the sub-$100M market cap sweet spot delivered November's most spectacular results.

Davis Commodities receiving reports from both Fugazi Research and BMF Reports within the same measurement period resulted in an 81.6% collapse followed by an additional 54.5% decline on the remaining value. Whether coordinated or coincidental, this convergence demonstrates a powerful dynamic: when multiple credible researchers independently identify the same target, the cumulative reputational damage and selling pressure can be catastrophic. This suggests an emerging playbook: vulnerable micro-caps that attract attention from one researcher may soon attract others, creating a cascading effect that amplifies individual impacts.

Hunterbrook Media published three reports in November, with wildly divergent outcomes: +13.2% (Archer), +2.2% (Papa Johns), and 55.8% (Sable Offshore). Yet their blended 13.5% negative average ranked them solidly in the top tier. This validates a volume-based approach to activist short selling. Not every thesis will land, but by maintaining publication velocity across diverse sectors and market caps, the winners more than compensate for the losers. The key is maintaining research quality while increasing throughput, something Hunterbrook appears to have mastered.

Agricultural commodities, offshore drilling, and healthcare services delivered November's strongest impacts, while aerospace/defense and biotech largely resisted. This pattern suggests that market receptivity to short theses varies dramatically by sector, influenced by prevailing narratives, valuation compression concerns, and regulatory environments. The agricultural commodity space, often overlooked by major researchers, proved especially vulnerable with both Davis Commodities reports generating massive moves. Meanwhile, breakthrough technology stories like Archer maintained momentum regardless of fundamental concerns. Smart researchers map these sector dynamics and concentrate fire where markets are already skeptical.

Stepping back, November's 15.1% average negative impact with 73% success rate demonstrates that activist short selling remains highly effective in the right market environment. This isn't a fluke, it's what happens when quality research meets receptive markets and appropriate target selection. Compare this to passive short strategies or systematic approaches, which rarely achieve double-digit average impacts. The activist short selling model, combining fundamental research, public disclosure, and targeted promotion, continues to deliver asymmetric results. November's performance, especially the extreme outliers like DTCK and SOC, shows that the potential for 50%+ single-report impacts remains very much alive in 2025.